ImmunoPrecise Antibodies Ltd. (IPA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about ImmunoPrecise Antibodies Ltd. (IPA)
Company Performance

Current Price

as of Oct 18, 2024

$0.54

P/E Ratio

N/A

Market Cap

$15.07M

Description

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Metrics

Overview

  • HQVictoria, BC
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerIPA
  • Price$0.54+0.19%

Trading Information

  • Market Cap$15.07M
  • Float87.48%
  • Average Daily Volume (1m)291,917
  • Average Daily Volume (3m)188,230
  • EPS-$0.76

Company

  • Revenue$17.73M
  • Rev Growth (1yr)-9.84%
  • Net Income-$2.92M
  • Gross Margin33.25%
  • EBITDA Margin-64.18%
  • EBITDA-$2.47M
  • EV$30.23M
  • EV/Revenue1.70
  • P/EN/A
  • P/S0.83
  • P/B0.62
Documents